Clinical Trial: Efficacy and Safety of Intravenous Dexamethasone Palmitate Treatments in Acute and Subacute Herpes Zoster Pain

U.S., Jan. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07344246) titled 'Efficacy and Safety of Intravenous Dexamethasone Palmitate Treatments in Acute and Subacute Herpes Zoster Pain' on Jan. 07.

Brief Summary: This is a randomized, prospective, multicenter, open-label, blinded-endpoint study investigating the efficacy and safety of dexamethasone palmitate (DXP) for treating acute and subacute herpes zoster (shingles) pain.

The study consists of four parallel sub-studies, each designed to answer a specific question:

Study 1: Compares intramuscular (IM) vs. intravenous (IV) administration of DXP (8mg) against standard therapy alone.

Study 2: Compares two different IV doses of DXP (4mg vs. 8mg) against...